RIBAVIRIN (RBV) DOSAGE AS INDEPENDENT PREDICTOR OF RVR IN HCV GENOTYPE 2 (HCV-2) AND 3 (HCV-3) PATIENTS UNDERGOING COMBINED TREATMENT WITH PEG INTERFERON (PEG-IFN) ALPHA-2B

Mangia, A. ; Dalgard, O. ; Minerva, N. ; Verbaan, Hans ; Scotto, G. ; Bacca, D. ; Agostinacchio, E. ; Bjoro, K. ; Carretta, V. ; Piazzolla, V. ; Cozzolongo, R. ; Romano, M. ; Mottola, L. ; Andriulli, A.

44th Annual Meeting of the European-Association-for-the-Study-of-the-Liver,Copenhagen, Denmark,2009-04-22 - 2009-04-26, 2009, Vol.50 (Suppl 1), p.232 [Periódico revisado por pares]

Texto completo disponível